Medicament for treating dog bites

Abstract

The invention relates to a medicament for treating dog bites. The medicament is characterized by comprising the following components in parts by weight: 6-12 parts of calculus bovis, 10-16 parts of ajuga taiwanensis, 4-10 parts of realgar, 3-9 parts of mistletoe, 4-10 parts of mylabris radix asparag, 5-13 parts of rabdosia rubescens, 1-6 parts of paris polyphylla, 1-5 parts of ciliatenerve knotweed root, 2-7 parts of amber, 2-8 parts of ternate grape fern herb, 1-10 parts of umbellate rock jasmine, 2-16 parts of garden burnet, 3-7 parts of black sesame powder, 2-6 parts of gadfly and 6-16 parts of apricot kernel. The medicament can overcome various imperfect defects in the prior art, the medicinal materials are easy to collect, convenient to transport and store and low in price. The medicament is particularly quick in apparent effect and healing human rabies in various morbidities, can be used for quickly inhibiting disease situations, and can be used for better avoiding physiological injuries on patients due to further dispersion of rabies virus.

Description

technical field [0001] The invention relates to a medicine for treating dog bites. Background technique [0002] Rabies is a human and zoonotic infectious disease caused by central nervous system infection caused by rabies virus, and is the most dangerous viral disease among all infectious diseases. The clinical application of various new drugs such as interferon a, vidarabine, transfer factor and high-dose human antirabies globulin all failed. Therefore, timely preventive treatment is emphasized after the bite, and the vaccines sold on the market for the treatment of rabies are live vaccines, which are not easy to transport and store, and the price is relatively high, especially for late-stage rabies patients. Typical symptoms and signs, the possibility of survival is extremely small, and the case fatality rate is almost 100%. Contents of the invention [0003] Aiming at the problems existing in the prior art, the purpose of the present invention is to provide a technic...

AI Technical Summary

Problems solved by technology

Therefore, timely preventive treatment is emphasized after the bite, and the vaccines sold on the market for the treatment of rabies are live vaccines, which are not easy to transport and store, and the price is relatively high, especially for late-stage rabies patients. Typical symptoms and signs, the possibility of survival is extremely small, and the case fatality rate is almost 100%.